Digital health app for CAR-T therapy self-management
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a digital health app to help you manage symptoms and stay connected with your care team while receiving CAR-T therapy as an outpatient. It's designed for people with blood cancers who have a caregiver living with them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer (like leukemia, lymphoma, or multiple myeloma) that has come back or hasn't responded to treatment
- You are scheduled to receive CAR-T therapy without staying overnight in the hospital
- You have a family member or friend who lives with you and helps with your care
- You are 18 years old or older
- You can read and understand English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how CAR T-cell treatment affects thinking, learning, and day-to-day brain function in children and young adults with certain blood cancers. You (and a caregiver) may complete online testing so researchers can track these changes over time and whether support is needed.
This study tests whether extra geriatric support before and after CAR-T cell therapy helps people 60 and older recover faster. It is for patients with B-cell non-Hodgkin lymphoma or multiple myeloma who are scheduled for an FDA-approved CAR-T treatment.
This study tests a mobile health app (PACT) to help people with advanced cancer talk and plan for future care. It may help you and a loved one stay engaged in advance care planning (planning what care you want and who should speak for you).
This trial tests a digital app to support patients receiving CAR-T therapy. It may help you track symptoms and communicate with your care team.
This study looks at how patients with blood cancers are managed in real life when they receive CAR-T cell therapy. It helps doctors learn more about how well these treatments work outside of clinical trials.
This trial tests a remote monitoring platform (app and home devices) to improve care for cancer patients with limited access to healthcare. It aims to help people who face barriers like not speaking English or having only government insurance.
Hear when a new Hematologic Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.